26 July 2012 - Northwest Biotherapeutics Inc. (OTC.BB: NWBO), a biotechnology company focused on developing immunotherapy products to treat cancers, has announced today that its German partner, Fraunhofer IZI, has received the official approval and certification from the regional and national regula...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up